Michael Mayersohn

5.1k citations
167 papers · 4.3k · h-index 35

Impact in

  • Pharmacology top 0.2%
    • Pharmacogenetics and Drug Metabolism
    • Antibiotics Pharmacokinetics and Efficacy
    • Drug Solubulity and Delivery Systems

Papers in

Michael Mayersohn

163 papers receiving 3.7k citations

Peers

Michael Mayersohn
Comparison fields: 5 of 134
  • Pharmacology 1.1k
  • Pharmaceutical Science 585
  • Toxicology 214
  • Pediatrics, Perinatology and Child Health 468
  • Small Animals 290
Replace Donald G. Perrier with:
Donald G. Perrier United States
Jiunn Huei Lin United States
Peter G. Welling United States
Tatsuji Iga Japan
Thorir D. Bjornsson United States
Yusuke Tanigawara Japan
Donna McTavish United States
Roger Karel Verbeeck Belgium
Felix Bochner Australia
Aziz Karim United States
Michael Mayersohn relative to Donald G. Perrier United States Donald G. Perrier's profile →
Citations per field
00.5×1.5×2×
Donald G. Perrier · 1×
Citations per year

Countries citing papers authored by Michael Mayersohn

Since Specialization
Citations

This map shows the geographic impact of Michael Mayersohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Mayersohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Mayersohn more than expected).

Fields of papers citing papers by Michael Mayersohn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Mayersohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Mayersohn. The network helps show where Michael Mayersohn may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Mayersohn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Mayersohn Line = papers co-authored together Michael Mayersohn links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 167 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1982262
2 1979242
3 1966128
4 2007118
5 2005116
6 1983110
7 1977103
8 197499
9 199996
10 196689
11 200476
12 198275
13 200674
14 200369
15 197964
16 197859
17 197258
18 199055
19 198853
20 199552

About Michael Mayersohn

Michael Mayersohn is a scholar working on Pharmacology, Pharmaceutical Science, Toxicology, Pediatrics, Perinatology and Child Health and Small Animals, having authored 167 papers that have together received 4.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (78 papers), Drug Solubulity and Delivery Systems (25 papers), Pharmaceutical studies and practices (24 papers), Forensic Toxicology and Drug Analysis (19 papers), Analytical Methods in Pharmaceuticals (15 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers), Animal testing and alternatives (11 papers) and Anesthesia and Sedative Agents (9 papers). The work is most often cited by research in Pharmacology (1.1k citations), Pharmaceutical Science (585 citations), Toxicology (214 citations), Pediatrics, Perinatology and Child Health (468 citations) and Small Animals (290 citations). Michael Mayersohn has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Donald G. Perrier, Huadong Tang, Milo Gibaldi, John M. Cobby, Gregory M. Marcus, Samuel Michael Owens, Wesley David Hager, Tarundeep Kakkar, Athiwat Hutchaleelaha and Ramanuj Achari. Their work appears in journals such as Journal of Pharmaceutical Sciences, Drug Metabolism and Disposition, Journal of Pharmacology and Experimental Therapeutics, Clinical Pharmacology & Therapeutics and The Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact